Featured Products

In our efforts to keep you informed of all developments within the R&D community, we would like to present to you the following featured product:

Linezolid CAS# 165800-03-3

IUPAC Name: (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS#: 165800-03-3 ATC code: J01XX08 PubChem: 441401 DrugBank: APRD01073 Formula: C16H20N3O4 Molecular mass: APRD01073 Assay/Purity: Typically NLT 98%

Linezolid is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. A member of the oxazolidinone class of drugs, linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA).

Linezolid is one of the best known antibiotics, and it is showing excellent performance in it's therapeutic segment. Linezolid is available for prompt delivery, usually within a few business days. Inquiries for all pack sizes welcome. Click here to inquire about this product.

New Product Categories

Antibiotics Antifungal

All of our products are available for prompt delivery. Inquiries for DMF, cGMP and all pack sizes welcome.

Call our customer support number (561) 981-9994, or contact us online at any time.

Disclaimer: Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

Recent Blog Posts

Linezolid shown effective against gram-positive bacteria Posted on: 1/6/11 Linezolid CAS #165800-03-3 is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. A member of the oxazolidinone class of drugs, Linezolid is active against most Gram-positive bacteria... More > Liraglutide is proven to help candidates control diabetes and lead to weight loss Posted on: 12/28/10 Liraglutide is a newly developed drug that is used to control the levels of blood glucose in patients suffering from type 2 Diabetes. In January 2010, the US Food and Drug Administration approved this drug for the treatment of patients... More > Eltrombopag brings feasible relief to Chronic ITP patients Posted on: 12/28/10 Eltrombopag is an effective drug that can help patients suffering from thrombocytopenia. This disease occurs when the percentage of platelets in the patient's blood... More > Dextromethorphan Hbr – A Drug That Affects Coughing, Laughing, Crying and Alleviates Pain Symptoms Posted on: 12/14/10 Dextromethorphan Hydrobromide is a well known cough suppressant drug. During a research study jointly funded by the CIA and the US Navy, Dextromethorphan Hbr was established.... More >